As XRP price accelerated its sell-off in June 2026, Finbold AI Agent – an advanced financial assistance tool – has made a bold XRP price prediction for July 31, 2026.
CNXC's AI push, offshore shift and cost cuts shape its margin path as management trims growth view but highlights stronger cash flow.
TD SYNNEX posts a record Q2 FY2026 as AI-driven infrastructure demand and Hyve Solutions growth fuel strong results, with hyperscaler wins and distribution strength.
SanDisk (NASDAQ: SNDK) stock has come a long way since the first regular session of 2026 as it soared from $275.24 to $2,050.39 at the latest close, and Wall Street analysts appear to believe the rally will slow down only slightly.
FMX, AVT, TLYS, RDDT and HG have been added to the Zacks Rank #1 (Strong Buy) List on June 30, 2026.
The new Digital Credit Capital Framework raises the STRC dividend to 12%, authorizes $2 billion in buybacks, and for the first time formally permits selling bitcoin at scale to fund the company's obligations.
Silver rebounds as Fed rate hike expectations cap gains before US labor data
BBIB, BGSI and CLCGY have been added to the Zacks Rank #5 (Strong Sell) List on June 30, 2026.
XRP is holding above the $1 mark even as its price action has stalled, with daily active addresses up roughly 72% in two weeks and derivatives leverage draining out of the market. Onchain Activity Heats Up XRP is clinging to $1 support, but the quiet in its price masks a pickup in network use.
Shares jumped after the company reported high demand across gas services, and said order visibility remained high.
Micron delivered record-breaking Q3 results, with revenue up 345.8% Y/Y and non-GAAP EPS at $25.11, far exceeding guidance. Strategic Customer Agreements now lock in 20% of DRAM and 33% of NAND capacity, providing $100B in performance obligations and raising the floor for future downcycles. Despite historically high margins, I expect some reversion as new supply arrives by 2028; SCAs provide partial downside protection but do not eliminate cyclicality.
Micron stock has gained 232% this quarter coming into Tuesday's session, according to Dow Jones Market Data.
Medline Inc. is rated a buy, driven by robust sector macroeconomics, strong ROE, organic Q1 growth, and a favorable Fitch investment-grade rating. MDLN's top-line growth is compelling, with net sales up 10.7% YoY, fueled by new customer signings and international market penetration. Despite positive revenue trends, MDLN faces margin pressure from rising costs, volatile cash flows, and a rich 37x forward earnings multiple, warranting caution.
FMX, AVT and BBDC made it to the Zacks Rank #1 (Strong Buy) income stocks list on June 30, 2026.
Bitcoin whales buy the dip as ETF outflows and rising exchange inflows reshape market sentiment.
Bitget has launched TradFi 101, a long-term educational initiative designed to help crypto users understand traditional financial markets and navigate the growing intersection between digital assets and global finance. The program introduces structured learning resources covering financial foundations, asset classes, market mechanics, macroeconomics, risk management, and the evolution of multi-asset investing. As tokenized assets become more accessible and investors increasingly participate across crypto, equities, commodities, ETFs, and real-world assets, financial literacy is becoming an essential skill for market participants. TradFi 101 is designed for a market environment where crypto-native investors can learn the drivers behind stocks, commodities, currencies, and capital flows.
Bitcoin ETFs lost $231M while Ethereum ETFs shed $30M, extending an eight-day outflow streak as June nears a record monthly decline.
Solana (SOL) climbed back into the mid-$70 range on Monday, leading a broader altcoin rebound as traders pointed to rising 'institutional adoption' and a growing pipeline of 'tokenized assets' on the network as key supports for demand. As of around 9:00 p.m.
The precious metal may have the calendar on its side, according to an analyst
SiriusPoint has evolved from a turnaround story into a disciplined specialty insurer with a significantly lower-risk underwriting profile. Continued reductions in catastrophe exposure are making earnings more durable rather than simply boosting one quarter's results. Capital allocation has shifted from balance sheet repair toward buybacks, preferred share redemptions, and long-term shareholder value creation.
eToro Group Ltd. (ETOR) remains a buy as its multi-asset platform demonstrates resilience and user stickiness beyond crypto cycles. ETOR's Q1 2026 saw 12% y/y funded account growth and 15% y/y AUA growth, with commodities driving a fourfold increase in trading volumes. ETOR's expanding product suite, including 24/7 trading and wealth products, aims to deepen user engagement and diversify monetization.
XRP (XRP) traded in a tight range around $1.04 on Monday, with investors closely watching whether the token can defend the psychologically important $1.00 level and reclaim key resistance zones that could signal a broader trend shift. While signs of steady 'institutional demand' are emerging through fund flows and on-chain activity, technicians say a sustainable rebound still hinges on a clean break above overhead resistance.
HG, DFIN and EFXT made it to the Zacks Rank #1 (Strong Buy) value stocks list on June 30, 2026.
Bitcoin is still trading below half of its all-time high price record, while the S&P 500, QQQ and gold continue to regularly set new records. The key reason for this prolonged underperformance was formulated by Tether adviser Gabor Gurbacs.
Singapore court has awarded more than $3 million in damages to 40 investors after finding Terraform Labs and co-founder Do Kwon liable for fraudulent misrepresentations tied to the 2022 TerraUSD collapse.
Micron (MU) remains a beneficiary of sustained AI-driven memory demand, though valuation is less compelling after a significant run-up. Current memory shortages are expected to persist, with hyperscalers and AI adoption driving robust demand and long-term contracts reducing near-term risk. MU trades at 12x–14x 2030 EPS estimates, with buybacks prioritized to return capital; cyclical risks and innovation-driven disruption remain key considerations.
The Danish biotechnology company and partner AbbVie said a drug combination to treat lymphoma met the primary goal in a late-stage clinical trial.
Doximity issued conservative FY2027 guidance, projecting 4% revenue growth and a 49% adjusted EBITDA margin, triggering a post-earnings stock selloff. I view the selloff as a temporary dislocation and a compelling buying opportunity for value investors given DOCS's resilient core platform usage. Management emphasized record physician engagement and continued dominance of DOCS's core products despite macroeconomic and regulatory headwinds.
Silver price today: Silver rises, according to FXStreet data
Congress is moving to fix how the US tax code treats crypto mining and staking rewards, and for validators and their institutional clients, the fix is long overdue. H.R.